Evidence map›Paper›PMID 40114481›Full record

ArticleEpidemiology and infection2025

Antimicrobial susceptibility of gram-negative strains isolated from bloodstream infections in China: Results from the study for monitoring antimicrobial resistance trends (SMART) 2018-2020.

Yili Chen, Pingjuan Liu, Huayin Li, Wenxiang Huang, Chunxia Yang, Mei Kang, Xiaofeng Jiang, Bin Shan, Hong He, Fupin Hu and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yili ChenDepartment of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.ORCID 0000-0003-0814-1249
Pingjuan LiuDepartment of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Huayin LiDivision of Microbiology, Zhongshan Hospital of Fudan University, Shanghai, China.
Wenxiang HuangDivision of Microbiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chunxia YangDepartment of Clinical Laboratory, Beijing Chao-Yang Hospital, Beijing, China.
Mei KangDepartment of Laboratory Medicine, West China School of Medicine, West China Hospital of Sichuan University, Chengdu, China.
Xiaofeng JiangDepartment of Clinical Laboratory, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Bin ShanDepartment of Clinical Laboratory, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Hong HeDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.
Fupin HuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Pengcheng LiV&I, Global Medical & Scientific Affairs, MSD China, Shanghai, China.
Yingchun XuDivision of Microbiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Kang LiaoDepartment of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.ORCID 0000-0002-7487-3651

Funding

Merck Sharp & Dohme LLC
6 · The paper itself

Abstract

The study aims were to present in vitro susceptibilities of clinical isolates from Gram-negative bacteria bloodstream infections (GNBSI) collected in China. GNBSI isolates were collected from 18 tertiary hospitals in 7 regions of China from 2018 to 2020. Minimum inhibitory concentrations were assessed using a Trek Diagnostic System. Susceptibility was determined using CLSI broth microdilution, and breakpoints were interpreted using CLSI M100 (2021). A total of 1,815 GNBSI strains were collected, with

Indexed as

Anti-Bacterial AgentsBacteremiaDrug Resistance, BacterialGram-Negative BacteriaGram-Negative Bacterial InfectionsChinaDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsAnti-Bacterial Agentsbloodstream infectioncarbapenem resistanceESBLgram-negative bacteriaSMART

Identifiers

PMID40114481
PMCPMC11951230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.